Bonesupport Holding AB (publ) (FRA:2B4)
Germany flag Germany · Delayed Price · Currency is EUR
16.93
+0.13 (0.77%)
At close: Dec 5, 2025

Bonesupport Holding AB Company Description

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection.

It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management.

In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery.

Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Bonesupport Holding AB (publ)
Country Sweden
Founded 1999
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 139
CEO Torbjorn Skold

Contact Details

Address:
Scheelevägen 19
Lund, 223 70
Sweden
Phone 46 4 62 86 53 70
Website bonesupport.com

Stock Details

Ticker Symbol 2B4
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency SEK
ISIN Number SE0009858152
SIC Code 3842

Key Executives

Name Position
Torbjorn Skold Chief Executive Officer
Håkan Johansson Chief Financial Officer
Michael Mortensen Chief Operating Officer